MYRIAD GENETICS, INC. SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense
MYRIAD GENETICS, INC. (MYGN) reported SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense of $33.29 million for the 12-month period ending 2013-06-30, per its 10-K filed 2013-08-14.
Discontinued › Notes › Valuation and Qualifying Accounts
us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense · last filed 2013-08-14
- MYRIAD GENETICS, INC. sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2013 was $33.29M, a 34.56% increase from fiscal 2012.
- MYRIAD GENETICS, INC. sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2012 was $24.74M, a 52.89% increase from fiscal 2011.
- MYRIAD GENETICS, INC. sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2011 was $16.18M, a 12.41% decline from fiscal 2010.
- MYRIAD GENETICS, INC. sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2010 was $18.48M.
| Period end | SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense 12 month |
|---|---|
| 2013-06-30 | $33.29M 10-K · filed 2013-08-14 |
| 2012-06-30 | $24.74M 10-K · filed 2013-08-14 |
| 2011-06-30 | $16.18M 10-K · filed 2013-08-14 |
| 2010-06-30 | $18.48M 10-K · filed 2012-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |